Literature DB >> 12414647

Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis.

Alison M Y Cheung1, M Prakash Hande, Farid Jalali, Ming-Sound Tsao, Brian Skinnider, Atsushi Hirao, J Peter McPherson, Jana Karaskova, Akira Suzuki, Andrew Wakeham, Annick You-Ten, Andrew Elia, Jeremy Squire, Rob Bristow, Razqallah Hakem, Tak W Mak.   

Abstract

BRCA2 is a breast cancer susceptibility gene of which the product is thought to be involved in monitoring genome integrity and cell cycle progression. Brca2-null mice have a defect in embryonic cellular proliferation and die in utero. Here we report the generation of T-cell lineage-specific Brca2-deficient (tBrca2(-/-)) mice using the Cre-loxP system. Mice with a flanked by loxP allele of Brca2 were crossed to transgenic mice bearing Cre recombinase driven by the T cell-specific promoter Lck. Thymic cellularity and distribution of subset populations were normal in tBrca2(-/-) mutants. Thymocytes from tBrca2(-/-) mice underwent normal apoptosis in response to a variety of stimuli, and activated tBrca2(-/-) T cells had normal proliferative capacity. tBrca2(-/-) T cells were more likely than wild-type cells to undergo spontaneous apoptosis, but apoptosed normally in response to restimulation or DNA-damaging stress signals. Examination of metaphase spreads of tBrca2(-/-) T cells revealed that the chromosomes often exhibited aberrations such as breaks and tri-radial structures. The level of chromosomal abnormalities was enhanced in T cells from tBrca2(-/-); p53(-/-) double-mutant mice. However, tBrca2(-/-); p53(-/-) T cells did not show the enhanced level of spontaneous apoptosis demonstrated by tBrca2(-/-) T cells, a difference that likely accounts for an increase in cell number and (3)[H]thymidine incorporation of double-mutant T cells in culture compared with either single mutant. Despite this increased T-cell number, the onset of T-cell lymphomas was only marginally accelerated in tBrca2(-/-); p53(-/-) mice compared with p53(-/-) mice. Our results support a role for Brca2 in repairing spontaneous DNA lesions, and suggest that loss of Brca2 enhances the susceptibility of mouse T-lineage cells to chromosomal aberrations and deregulation of apoptosis in the absence of p53.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414647

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.

Authors:  Sridharan Rajagopalan; Antonina Andreeva; Trevor J Rutherford; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

Review 2.  The sticky business of histone H2AX in V(D)J recombination, maintenance of genomic stability, and suppression of lymphoma.

Authors:  Bu Yin; Craig H Bassing
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Loss of DNA polymerase zeta enhances spontaneous tumorigenesis.

Authors:  John P Wittschieben; Vaishali Patil; Veronika Glushets; Lisa J Robinson; Donna F Kusewitt; Richard D Wood
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

Review 4.  BRCA1 and BRCA2: different roles in a common pathway of genome protection.

Authors:  Rohini Roy; Jarin Chun; Simon N Powell
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

5.  Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.

Authors:  Eleonora Sementino; Craig W Menges; Yuwaraj Kadariya; Suraj Peri; Jinfei Xu; Zemin Liu; Richard G Wilkes; Kathy Q Cai; Frank J Rauscher; Andres J Klein-Szanto; Joseph R Testa
Journal:  J Cell Physiol       Date:  2018-06-15       Impact factor: 6.384

6.  Requirement for dicer in survival of proliferating thymocytes experiencing DNA double-strand breaks.

Authors:  Brenna L Brady; Levi J Rupp; Craig H Bassing
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

7.  Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis.

Authors:  Jeffrey C Francis; Afshan McCarthy; Martin K Thomsen; Alan Ashworth; Amanda Swain
Journal:  PLoS Genet       Date:  2010-06-24       Impact factor: 5.917

8.  Development of thymic lymphomas in mice disrupted of Brca2 allele in the thymus.

Authors:  Pil-Gu Park; Hyunsook Lee
Journal:  Exp Mol Med       Date:  2008-06-30       Impact factor: 8.718

9.  53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.

Authors:  Julio C Morales; Sonia Franco; Michael M Murphy; Craig H Bassing; Kevin D Mills; Melissa M Adams; Nicole C Walsh; John P Manis; George Z Rassidakis; Frederick W Alt; Phillip B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

10.  Somatic inactivation of Tp53 in hematopoietic stem cells or thymocytes predisposes mice to thymic lymphomas with clonal translocations.

Authors:  Amy DeMicco; Katherine Yang-Iott; Craig H Bassing
Journal:  Cell Cycle       Date:  2013-09-09       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.